Biometrical Journal

Papers
(The median citation count of Biometrical Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The Replication of Equivalence Studies142
Blinded sample size recalculation in multiple composite population designs with normal data and baseline adjustments53
On the role of benchmarking data sets and simulations in method comparison studies49
A comparison of the multilevel MIMIC model to the multilevel regression and mixed ANOVA model for the estimation and testing of a cross‐level interaction effect: A simulation study49
Bootstrap tests for simultaneous monotone ordering of effects in a two‐way ANOVA46
Parametric modal regression with error in covariates34
On the relevance of prognostic information for clinical trials: A theoretical quantification30
Bayesian Nonparametric Sensitivity Analysis of Multiple Test Procedures Under Dependence25
Flexible cloglog links for binomial regression models as an alternative for imbalanced medical data25
Evaluating Causal Effects on Time‐to‐Event Outcomes in an RCT in Oncology With Treatment Discontinuation22
Penalized estimation of a class of single‐index varying‐coefficient models for integrative genomic analysis22
Multiple Contrast Tests for Count Data: Small Sample Approximations and Their Limitations20
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression‐Free and Overall Survival Endpoints19
Risk‐Based Decision Making: Estimands for Sequential Prediction Under Interventions16
A Bayesian hierarchical hidden Markov model for clustering and gene selection: Application to kidney cancer gene expression data15
Contents: Biometrical Journal 6'2215
Adaptive Multiple Comparisons With the Best15
Explained variation and degrees of necessity and of sufficiency for competing risks survival data15
Multivariate joint model under competing risks to predict death of hospitalized patients for SARS‐CoV‐2 infection14
Estimating the Optimal Time to Perform a Positron Emission Tomography With Prostate‐Specific Membrane Antigen in Prostatectomized Patients, Based on Data From Clinical Practice14
Exact sample size determination for a single Poisson random sample14
Recoverability and estimation of causal effects under typical multivariable missingness mechanisms13
Multistate modeling and structure selection for multitype recurrent events and terminal event data13
Online false discovery rate control for LORD++ and SAFFRON under positive, local dependence12
Trial arm outcome variance difference after dropout as an indicator of missing‐not‐at‐random bias in randomized controlled trials12
Analysis of survival data with nonproportional hazards: A comparison of propensity‐score‐weighted methods11
A zero‐inflated endemic–epidemic model with an application to measles time series in Germany11
Landmarking for Left‐Truncated Competing Risk Data11
Comparison of cohort and nested case‐control designs for estimating the effect of time‐varying drug exposure on the risk of adverse event in the presence of ties10
Intercept Estimation of Semi‐Parametric Joint Models in the Context of Longitudinal Data Subject to Irregular Observations10
Masthead: Biometrical Journal 1'2310
Impact of Methodological Assumptions and Covariates on the Cutoff Estimation in ROC Analysis10
Post‐Estimation Shrinkage in Full and Selected Linear Regression Models in Low‐Dimensional Data Revisited10
Modified Skew Discrete Laplace Regression Models for Integer‐Valued Data With Applications to Paired Samples9
Sample size calculation for the combination test under nonproportional hazards9
Finite mixtures in capture–recapture surveys for modeling residency patterns in marine wildlife populations9
Sharp Bounds for Continuous‐Valued Treatment Effects with Unobserved Confounders9
9
New weighting methods when cases are only a subset of events in a nested case‐control study9
9
Estimation in optimal treatment regimes based on mean residual lifetimes with right‐censored data8
Model misspecification and bias for inverse probability weighting estimators of average causal effects8
Dimension Reduction for the Conditional Quantiles of Functional Data With Categorical Predictors8
Signpost Testing to Navigate the Parameter Space of the Gaussian Graphical Model With High‐Dimensional Data8
Smoothed quantile regression for partially functional linear models in high dimensions8
A unified framework for weighted parametric group sequential design7
Incompletely Observed Nonparametric Factorial Designs With Repeated Measurements: A Wild Bootstrap Approach7
Cover Picture: Biometrical Journal 7'227
Editorial Board: Biometrical Journal 8'227
Bayesian dose escalation with overdose and underdose control utilizing all toxicities in Phase I/II clinical trials7
Cover Picture: Biometrical Journal 2'237
7
Multivariate Bayesian Dynamic Borrowing for Repeated Measures Data With Application to External Control Arms in Open‐Label Extension Studies7
A two‐way additive model with unknown group‐specific interactions applied to gene expression data7
Biomarker‐based precision dose finding for immunotherapy combined with radiotherapy7
A New Mixture Model With Cure Rate Applied to Breast Cancer Data6
Reflections on the concept of optimality of single decision point treatment regimes6
Non‐Markov Nonparametric Estimation of Complex Multistate Outcomes After Hematopoietic Stem Cell Transplantation6
A New Approach to the Nonparametric Behrens–Fisher Problem With Compatible Confidence Intervals6
A frequentist approach to dynamic borrowing6
An adjusted coefficient of determination (R2) for generalized linear mixed models in one go6
Network Meta‐Analysis of Time‐to‐Event Endpoints With Individual Participant Data Using Restricted Mean Survival Time Regression6
A gentle tutorial on accelerated parameter and confidence interval estimation for hidden Markov models using Template Model Builder6
6
Bayesian Inference of Phenotypic Plasticity of Cancer Cells Based on Dynamic Model for Temporal Cell Proportion Data6
Masthead: Biometrical Journal 7'236
A nonparametric method for classification trees using grouped covariates5
Bayesian and influence function‐based empirical likelihoods for inference of sensitivity to the early diseased stage in diagnostic tests5
A neutral comparison of statistical methods for analyzing longitudinally measured ordinal outcomes in rare diseases5
Rethinking Probability of Success as Bayes Utility5
Combining Partial True Discovery Guarantee Procedures5
Comparing algorithms for characterizing treatment effect heterogeneity in randomized trials5
5
Developing and Comparing Four Families of Bayesian Network Autocorrelation Models for Binary Outcomes: Estimating Peer Effects Involving Adoption of Medical Technologies5
Blinded sample size recalculation in adaptive enrichment designs5
Simultaneous confidence intervals for quantile differences of several heterogeneous normal populations: With application to vitamin D supplement treatment on colorectal cancer patients5
Multivariate reference and tolerance regions based on conditional transformation models: Application to glycemic markers5
Estimation of odds ratio from group testing data with misclassified exposure4
Bayesian Integrative Detection of Structural Variations With False Discovery Rate Control4
Semi‐supervised empirical Bayes group‐regularized factor regression4
A Network‐Constrain Weibull AFT Model for Biomarkers Discovery4
A mechanistic spatio‐temporal modeling of COVID‐19 data4
Issue Information: Biometrical Journal 7'244
Random‐effects meta‐analysis models for the odds ratio in the case of rare events under different data‐generating models: A simulation study4
Masthead: Biometrical Journal 4'234
Using marginal structural joint models to estimate the effect of a time‐varying treatment on recurrent events and survival: An application on arrhythmogenic cardiomyopathy4
Variable selection for nonparametric additive Cox model with interval‐censored data4
Functional Multivariable Logistic Regression With an Application to HIV Viral Suppression Prediction4
Comparison of likelihood penalization and variance decomposition approaches for clinical prediction models: A simulation study4
Revisiting Hazard Ratios: Can We Define Causal Estimands for Time‐Dependent Treatment Effects?4
Random Survival Forests With Competing Events: A Subdistribution‐Based Imputation Approach4
Drug combinations screening using a Bayesian ranking approach based on dose–response models4
Cross‐Cohort Mixture Analysis: A Data Integration Approach With Applications on Gestational Age and DNA‐Methylation‐Derived Gestational Age Acceleration Metrics4
Joint Model for Interval‐Censored Semicompeting Events and Longitudinal Data With Subject‐Specific Within‐ and Between‐Visits Variabilities4
Incorporating infectious duration‐dependent transmission into Bayesian epidemic models4
Comparison of statistical models to predict age‐standardized cancer incidence in Switzerland4
Simulating Data From Marginal Structural Models for a Survival Time Outcome4
4
Editorial Board: Biometrical Journal 3'234
Contents: Biometrical Journal 7'224
Mediation analysis with case–control sampling: Identification and estimation in the presence of a binary mediator4
Bayesian two‐stage sequential enrichment design for biomarker‐guided phase II trials for anticancer therapies3
Masthead: Biometrical Journal 8'233
Causal Effect Estimation With TMLE: Handling Missing Data and Near Violations of Positivity3
Mediation Analysis With Exposure–Mediator Interaction and Covariate Measurement Error Under the Additive Hazards Model3
Editorial Board: Biometrical Journal 1'243
A comparative study of in vitro dose–response estimation under extreme observations3
A New Inverse Probability of Selection Weighted Cox Model to Deal With Outcome‐Dependent Sampling in Survival Analysis3
Some new results on Cox–Czanner divergence and their applications in survival studies3
Cover Picture: Biometrical Journal 7'233
A Regularized MANOVA Test for Semicontinuous High‐Dimensional Data3
In memory of Carmen María Cadarso Suárez (1960–2022)3
Interpretability of bi‐level variable selection methods3
A comparison of full model specification and backward elimination of potential confounders when estimating marginal and conditional causal effects on binary outcomes from observational data3
Surrogacy validation for time‐to‐event outcomes with illness‐death frailty models3
Issue Information: Biometrical Journal 2'253
Issue Information: Biometrical Journal 1'263
Generalized Boosted Models to Measure Racial Effects at Different Quantiles in Observational Studies3
Sparse multiway canonical correlation analysis for multimodal stroke recovery data3
The marginality principle revisited: Should “higher‐order” terms always be accompanied by “lower‐order” terms in regression analyses?3
Identifying the Best Predictive Biomarker in Pharmacogenomics Through Multiple Comparisons With the Best3
On near‐redundancy and identifiability of parametric hazard regression models under censoring3
A likelihood ratio test for completed sampling in population size estimation studies3
Stratified modestly weighted log‐rank tests in settings with an anticipated delayed separation of survival curves3
Impact of Treatment Effect Heterogeneity on the Estimation of Individualized Treatment Rules for Count Outcomes3
High‐dimensional feature selection in competing risks modeling: A stable approach using a split‐and‐merge ensemble algorithm3
A Bayesian approach for subgroup analysis3
Group Integrative Dynamic Factor Models With Application to Multiple Subject Brain Connectivity3
Editorial Board: Biometrical Journal 1'233
Masthead: Biometrical Journal 2'233
M‐quantile regression shrinkage and selection via the Lasso and Elastic Net to assess the effect of meteorology and traffic on air quality3
Editorial Board: Biometrical Journal 6'233
Masthead: Biometrical Journal 6'232
A Novel Approach to the Design and Sample Size Planning of Animal Experiments Based on Effect Estimation2
Issue Information: Biometrical Journal 3'262
Single‐arm Phase II Survival Trial Design. JianrongWu(2021). Boca Raton: Chapman & Hall/CRC Press. 273 pages. ISBN: 978‐0‐3676‐5345‐3. List price: £130 (Hardback), £40.49 (eBook)2
High‐Dimensional Bayesian Semiparametric Models for Small Samples: A Principled Approach to the Analysis of Cytokine Expression Data2
Enhancing estimation methods for integrating probability and nonprobability survey samples with machine‐learning techniques. An application to a Survey on the impact of the COVID‐19 pandemic in Spain2
Comparing linear discriminant analysis and supervised learning algorithms for binary classification—A method comparison study2
Contents: Biometrical Journal 5'222
Evaluating cancer screening programs using survival analysis2
Confidence intervals for discrete data in clinical research by VivekPradhan, Ashis K.Gangopadhyay, Sandeep M.Menon, CynthiaBasu, TathagataBanerjee.Boca Raton, FL: Chapman & Hall/CRC Press. 2022. 22
Individual risk prediction: Comparing random forests with Cox proportional‐hazards model by a simulation study2
A method for determining groups in cumulative incidence curves in competing risk data2
Decoupling power and type I error rate considerations when incorporating historical control data using a test‐then‐pool approach2
Cover Picture: Biometrical Journal 4'232
Adapting SIMEX to correct for bias due to interval‐censored outcomes in survival analysis with time‐varying exposure2
Multiplicity adjustments for the Dunnett procedure under heterokcedasticity2
Outcomes Truncated by Death in RCTs: A Simulation Study on the Survivor Average Causal Effect2
Linear mixed models. A practical guide using statistical software by Brady T.West, Kathleen B.Welch, Andrzej T.Gałecki, third edition, New York: Chapman & Hall/CRC. 2022. 489 pages. ISBN: 978‐1‐002
Sample Size Calculation for an Individual Stepped‐Wedge Randomized Trial2
τ$\tau$‐Inflated Beta Regression Model for Estimating τ$\tau$‐Restricted Means and Event‐Free Probabilities for Censored Time‐to‐Event Data2
Contrasting Global and Patient‐Specific Regression Models via a Neural Network Representation2
Generalizing the Finkelstein–Schoenfeld Test to Incorporate Multiple Alternating Thresholds2
Response‐adaptive randomization for multiarm clinical trials using context‐dependent information measures2
Generalized Bayesian Inference for Causal Effects Using the Covariate Balancing Procedure2
2
A spatial model to jointly analyze self‐reported survey data of COVID‐19 symptoms and official COVID‐19 incidence data2
Influence of cluster‐period cells in stepped wedge cluster randomized trials2
Functional Data Analysis: An Introduction and Recent Developments2
2
Pitfalls and potentials in simulation studies: Questionable research practices in comparative simulation studies allow for spurious claims of superiority of any method2
2
Mixture Cure Semiparametric Accelerated Failure Time Models With Partly Interval‐Censored Data2
On repeated diagnostic testing in screening for a medical condition: How often should the diagnostic test be repeated?2
Analysis of Nonconcurrent Controls in Adaptive Platform Trials: Separating Randomized and Nonrandomized Information2
Robust incorporation of historical information with known type I error rate inflation2
Firth‐Type Penalized Methods of the Modified Poisson and Least‐Squares Regression Analyses for Binary Outcomes2
A novel nonparametric time‐dependent precision–recall curve estimator for right‐censored survival data2
Domain Selection for Gaussian Process Data: An Application to Electrocardiogram Signals2
An approximate Bayesian approach for estimation of the instantaneous reproduction number under misreported epidemic data2
Sensitivity Analysis for Effects of Multiple Exposures in the Presence of Unmeasured Confounding2
On the choice of timescale for other cause mortality in a competing risk setting using flexible parametric survival models2
Confirmatory Adaptive Designs for Clinical Trials With Multiple Time‐to‐Event Outcomes in Multi‐state Markov Models2
A Preplanned Multi‐Stage Platform Trial for Discovering Multiple Superior Treatments With Control of FWER and Power2
Pseudo‐Observation Approach for Length‐Biased Cox Proportional Hazards Model2
How Should Parallel Cluster Randomized Trials With a Baseline Period be Analyzed?—A Survey of Estimands and Common Estimators2
A joint Bayesian framework for missing data and measurement error using integrated nested Laplace approximations2
Sparse Group Penalties for bi‐level variable selection2
A note of feature screening via a rank‐based coefficient of correlation2
Goodness‐of‐Fit Testing for a Regression Model With a Doubly Truncated Response2
Causal inference in the absence of positivity: The role of overlap weights2
Issue Information: Biometrical Journal 3'242
Issue Information: Biometrical Journal 4'252
Masthead: Biometrical Journal 7'222
Inferring on Joint Associations From Marginal Associations and a Reference Sample2
A Covariance‐Based Penalty Estimator for Model Assessment With Censored Data2
2
Toward Power Analysis for Partial Least Squares‐Based Methods2
Semiparametric Additive Modeling of the Restricted Mean Survival Time2
A comparison of strategies for selecting auxiliary variables for multiple imputation1
Statistical issues in drug development by StephenSenn, third edition, New York: John Wiley & Sons. 2021. 640 p. USD 120.00. ISBN: 978‐1‐119‐23857‐71
Modified Conditional Borrowing‐By‐Part Power Prior for Dynamic and Parameter‐Specific Information Borrowing of the Gaussian Endpoint1
Clinical biostatistics in the 2020s1
The Locally Active‐Controlled Optimal Design: Applications in Oncology Clinical Studies1
Unbiased and efficient estimation of causal treatment effects in crossover trials1
A Semiparametric Two‐Sample Density Ratio Model With a Change Point1
A Bayesian model‐based reduced major axis regression1
The DeepJoint Algorithm: An Innovative Approach for Studying the Longitudinal Evolution of Quantitative Mammographic Density and Its Association With Screen‐Detected Breast Cancer Risk1
Regression Analysis of Arbitrarily Censored and Left‐Truncated Data Under the Proportional Odds Model1
Extending t linear mixed models for longitudinal data with non‐ignorable dropout applied to AIDS studies1
Multivariate Scalar on Multidimensional Distribution Regression With Application to Modeling the Association Between Physical Activity and Cognitive Functions1
A Bayesian Basket Trial Design Using Local Power Prior1
Estimating the prevalence of two or more diseases using outcomes from multiplex group testing1
Investigating the Heterogeneity of “Study Twins”1
1
Masthead: Biometrical Journal 5'221
Two‐Arm Crossover Randomized Controlled Trial Versus Meta‐Analysis of N‐of‐1 Studies: Comparison of Statistical Efficiency in Determining an Intervention Effect1
Cover Picture: Biometrical Journal 6'231
To Tweak or Not to Tweak. How Exploiting Flexibilities in Gene Set Analysis Leads to Overoptimism1
False Discovery Rate Control for Lesion‐Symptom Mapping With Heterogeneous Data via Weighted p‐Values1
Cover Picture: Biometrical Journal 8'231
Sample size calculation for one‐armed clinical trials with clustered data and binary outcome1
Unscaled Indices for Assessing Agreement of Functional Data1
Adaptive data collection for intraindividual studies affected by adherence1
Survivor Average Causal Effects for Continuous Time: A Principal Stratification Approach to Causal Inference With Semicompeting Risks1
Federated Mixed Effects Logistic Regression Based on One‐Time Shared Summary Statistics1
Editorial for the special collection “Towards neutral comparison studies in methodological research”1
Assessing Balance of Baseline Time‐Dependent Covariates via the Fréchet Distance1
TITE‐gBOIN‐ET: Time‐to‐event generalized Bayesian optimal interval design to accelerate dose‐finding accounting for ordinal graded efficacy and toxicity outcomes1
Estimating the Sampling Distribution of Posterior Decision Summaries in Bayesian Clinical Trials1
1
Flexible Parametric Accelerated Failure Time Models With Cure1
Years of Life Lost to COVID‐19 and Related Mortality Indicators: An Illustration in 30 Countries1
Sample Size Calculation Under Nonproportional Hazards Using Average Hazard Ratios1
Inverse‐Weighted Quantile Regression With Partially Interval‐Censored Data1
A Bivariate Finite Mixture Random Effects Model for Identifying and Accommodating Outliers in Diagnostic Test Accuracy Meta‐Analyses1
Efficient testing and effect size estimation for set‐based genetic association inference via semiparametric multilevel mixture modeling1
Sample size planning for rank‐based multiple contrast tests1
Cover Picture: Biometrical Journal 6'221
Regularized parametric survival modeling to improve risk prediction models1
Empirical Likelihood Comparison of Absolute Risks1
gBOIN‐ET: The generalized Bayesian optimal interval design for optimal dose‐finding accounting for ordinal graded efficacy and toxicity in early clinical trials1
On the use of cross‐validation for the calibration of the adaptive lasso1
Generalizing treatment effects with incomplete covariates: Identifying assumptions and multiple imputation algorithms1
Designing multicenter individually randomized group treatment trials1
1
Statistical review of animal trials—A guideline1
Efficient Testing Using Surrogate Information1
Testing for Sufficient Follow‐Up in Survival Data With a Cure Fraction1
Bayesian Structure Learning for Graphical Models With Symmetry Constraints1
Predicting class switch recombination in B‐cells from antibody repertoire data1
Informative Co‐Data Learning for High‐Dimensional Horseshoe Regression1
Explaining the optimistic performance evaluation of newly proposed methods: A cross‐design validation experiment1
Health Care Provider Clustering Using Fusion Penalty in Quasi‐Likelihood1
Analysis of Multiple Outcomes in Contaminated Trials Reinforced With Validation Data1
Cover Picture: Biometrical Journal 1'231
Multiple testing of composite null hypotheses for discrete data using randomized p‐values1
Letter to the editor regarding the paper “New weighting methods when cases are only a subset of events in a nested case‐control study” by Qian M. Zhou, Xuan Wang, Yingye Zheng, and Tianxi Cai1
Multivariate linear mixed models with censored and nonignorable missing outcomes, with application to AIDS studies1
0.082226991653442